Needham Maintains Buy on Trulieve Cannabis, Lowers Price Target to $9
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Matt McGinley has maintained a 'Buy' rating on Trulieve Cannabis (OTC:TCNNF) but lowered the price target from $10 to $9.
August 10, 2023 | 8:38 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst has maintained a 'Buy' rating on Trulieve Cannabis but lowered the price target from $10 to $9.
The news is directly related to Trulieve Cannabis (TCNNF). The maintained 'Buy' rating indicates a positive outlook for the company, however, the lowered price target might indicate a slower growth expectation. This could have a neutral impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100